COMPARISON OF THE CYTO-TOXIC ACTIVITIES OF CHEMOTHERAPEUTIC DRUGS USING A HUMAN BLADDER-CANCER CELL-LINE

被引：13

作者：

HEPBURN, PJ

OLIVER, RTD

RILEY, PA

HILL, BT

MASTERS, JRW

机构：

[1] IMPERIAL CANC RES FUND,CELLULAR CHEMOTHERAPY,LONDON,ENGLAND

[2] ST PAULS HOSP,INST UROL,DEPT ONCOL,LONDON WC2,ENGLAND

[3] UNIV LONDON UNIV COLL,SCH MED,DEPT BIOCHEM PATHOL,LONDON WC1E 6BT,ENGLAND

来源：

UROLOGICAL RESEARCH | 1985年 / 13卷 / 01期

关键词：

D O I：

10.1007/BF00571753

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：27 / 34

页数：8

共 52 条

[1] ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY [J].

ACHTERRATH, W ;

NIEDERLE, N ;

RAETTIG, R ;

HILGARD, P .

CANCER TREATMENT REVIEWS, 1982, 9 :3-13

[2]

ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177

[3]

ALBERTS DS, 1981, P NCI EORTC S NEW DR

[4]

ALBERTS DS, 1980, CLONING HUMAN TUMOR, P197

[5]

ALBERTS DS, 1983, 13TH INT P C CHEM VI

[6]

Alberts DS, 1980, CLONING HUMAN TUMOR, P351

[7] CLINICAL PHARMACOKINETICS OF COMMONLY USED ANTI-CANCER DRUGS [J].

BALIS, FM ;

HOLCENBERG, JS ;

BLEYER, WA .

CLINICAL PHARMACOKINETICS, 1983, 8 (03) :202-232

[8]

BELEJ MA, 1972, CLIN PHARMACOL THER, V13, P563

[9]

BELT RJ, 1979, CANCER TREAT REP, V63, P1515

[10]

BENJAMIN RS, 1977, CANCER RES, V37, P1416

← 1 2 3 4 5 6 →